Publications

Division/Center

Overall survival benefits of cancer drugs in the WHO Model List of Essential Medicines, 2015-2021.

BMJ Glob Health
Zhou Y, Naci H, Chen D, Bai L, Shi L, Guan X, Wagner AK

Mental Health Outcomes Among Patients Living in US Counties Lacking Broadband Access and Psychiatrists.

JAMA Netw Open
Ramesh T, McBain RK, Cantor JH, Stein BD, Yu H

Changing Tides? Anticancer Biologic and Biosimilar Use in Medicare Part B, 2019-2021.

JCO Oncol Pract
McClean AR, Wagner AK, Lu CY

Utilization and Spending With Preventive Drug Lists for Asthma Medications in High-Deductible Health Plans.

JAMA Netw Open
Sinaiko AD, Ross-Degnan D, Wharam JF, LeCates RF, Wu AC, Zhang F, Galbraith AA

Evaluation of the Conrad 30 Waiver Program's Success in Attracting International Medical Graduates to Underserved Areas.

JAMA Health Forum
Ramesh T, Brotherton SE, Wozniak GD, Yu H

The Impact of Prescribing Monitoring Policy on Drug Use and Expenditures in China: A Multi-center Interrupted Time Series Study.

Int J Health Policy Manag
Nie X, Wang R, Liang G, Zhang X, Tang N, Cai Y, Han C, Zhao Y, Jia T, Zhang F, Han S, Guan X, Shi L, Lu CY

Regional and temporal trends of falls and injurious falls among Chinese older adults: results from China Health and Retirement Longitudinal Study, 2011-2018.

Inj Prev
Liu Y, Kabba JA, Xu S, Gu H, Su X, Liu Y, Yu H

Marketing authorisation and pricing of FDA-approved cancer drugs in Brazil: a retrospective analysis.

Lancet Reg Health Am
Ivama-Brummell AM, Marciniuk FL, Wagner AK, Osorio-de-Castro CGS, Vogler S, Mossialos E, Tavares-de-Andrade CL, Naci H

The Pediatrician Workforce in the United States and China.

Pediatrics
Russ CM, Gao Y, Karpowicz K, Lee S, Stephens TN, Trimm F, Yu H, Jiang F, Palfrey J

The Effectiveness of Enhanced Primary Healthcare (EnPHC) interventions on Type 2 diabetes management in Malaysia: Difference-in-differences (DID) analysis.

Prim Care Diabetes
Husin M, Teh XR, Ong SM, Lim YMF, Ang SH, Chan CL, Lim MT, Shanmugam S, Khamis N, Jaafar FSA, Ibrahim NI, Nasir NH, Kusuma D, Wagner AK, Ross-Degnan D, Atun R, Sivasampu S

Snuff burnout and reignite passion in medical students.

Med Educ
Laird-Gion JN, Garabedian LF, Conrad R, Shaffer AC, Witkowski ML, Mateo CM, Jones DS, Hundert E, Kasper J

Association Between Preapproval Confirmatory Trial Initiation and Conversion to Traditional Approval or Withdrawal in the FDA Accelerated Approval Pathway.

JAMA
Shahzad M, Naci H, Wagner AK

Newly approved cancer drugs in China - innovation and clinical benefit.

Nat Rev Clin Oncol
Zhang Y, Wagner AK, Guan X

Medical Marijuana Legalization and Opioid- and Pain-Related Outcomes Among Patients Newly Diagnosed With Cancer Receiving Anticancer Treatment.

JAMA Oncol
Bao Y, Zhang H, Bruera E, Portenoy R, Rosa WE, Reid MC, Wen H

Overall Survival Benefits of Cancer Drugs Approved in China From 2005 to 2020

Potential Bias of Instrumental Variable Analysis in Comparative Effectiveness Research for Bariatric Surgery.

JAMA Netw Open
Garabedian LF

Overall Survival Benefits of Cancer Drugs Approved in China From 2005 to 2020.

JAMA Netw Open
Zhang Y, Naci H, Wagner AK, Xu Z, Yang Y, Zhu J, Ji J, Shi L, Guan X

Evaluating Natural Experiments that Impact the Diabetes Epidemic: an Introduction to the NEXT-D3 Network.

Curr Diab Rep
Siegel KR, Ali MK, Ackermann RT, Black B, Huguet N, Kho A, Mangione CM, Nauman E, Ross-Degnan D, Schillinger D, Shi L, Wharam JF, Duru OK

New-onset cancer cases in FDA's Sentinel System: a large distributed system of US electronic healthcare data.

Cancer Epidemiol Biomarkers Prev
Haug NR, Wagner AK, McGlynn KA, Leonard CE, Nguyen MD, Major JM

Health Economics Research in Cancer Screening: Research Opportunities, Challenges, and Future Directions.

J Natl Cancer Inst Monogr
Shih YT, Sabik LM, Stout NK, Halpern MT, Lipscomb J, Ramsey S, Ritzwoller DP